PHIGENIX Appoints Michael C. Shores to Board of Directors

PHIGENIX Inc., a developer of diagnostic tools and targeted therapies for cancer, today announced it has appointed Michael C. Shores to the Board of Directors.(PRWeb January 11, 2018)Read the full story at http://www.prweb.com/releases/2018/01/prweb15079100.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news